Coverage
-
August 15, 2023
The Fourth Circuit on Tuesday revived a False Claims Act suit alleging Walgreens falsely certified that certain Virginia Medicaid patients were eligible for hepatitis C drugs, finding the misrepresentations had a direct impact on the government's decision to pay out the unwarranted reimbursements.
2 other articles on this case.
View all »